Open Forum Infect Dis

Abstract

Using a coronavirus disease 2019 (COVID-19)-associated hospitalization surveillance network, we found that 42.5% of hospitalized COVID-19 cases with available data from March 1-June 30, 2020, received 651 COVID-19 investigational treatment. Hydroxychloroquine, azithromycin, and remdesivir were used frequently; however, hydroxychloroquine and azithromycin use declined over time, while use of remdesivir increased.20202021-11-09T00:00:00Z33274249PMC7686662883

Extracted data

We use cookies to provide a better user experience.

Data Protection

Open Forum Infect Dis

Open link

Abstract

Extracted data

Vivanco-Hidalgo, Rosa Maria
Molina, Israel
Martinez, Elisenda
Roman-Viñas, Ramón
Sánchez-Montalvá, Adrián
Fibla, Joan
Pontes, Caridad
Velasco Muñoz, César

Several clinical trials have assessed the protective potential of chloroquine and hydroxychloroquine...

Pharmacoepidemiology, Machine Learning, and COVID-19: An Intent-to-Treat Analysis of Hydroxychloroquine, With or Without Azithromycin, and COVID-19 Outcomes Among Hospitalized US Veterans.

Gerlovin, Hanna
Posner, Daniel C
Ho, Yuk-Lam
Rentsch, Christopher T
Tate, Janet P
King, Joseph T
Kurgansky, Katherine E
Danciu, Ioana
Costa, Lauren
Linares, Franciel A
Goethert, Ian D
Jacobson, Daniel A
Freiberg, Matthew S
Begoli, Edmon
Muralidhar, Sumitra
Ramoni, Rachel B
Tourassi, Georgia
Gaziano, J Michael
Justice, Amy C
Gagnon, David R
Cho, Kelly

June 2021

Hydroxychloroquine (HCQ) was proposed as an early therapy for coronavirus disease 2019 (COVID-19) af...

Heterogeneity and temporal variation in the management of COVID-19: a multinational drug utilization study including 71,921 hospitalized patients from China, South Korea, Spain, and the United States of America

Albert Prats-Uribe
Anthony G. Sena
Lana Yin Hui Lai
Waheed-Ul-Rahman Ahmed
Heba Alghoul
Osaid Alser
Thamir M Alshammari
Carlos Areia
William Carter
Paula Casajust
Dalia Dawoud
Asieh Golozar
Jitendra Jonnagaddala
Paras Mehta
Gong Menchung
Daniel R Morales
Fredrik Nyberg
Jose D Posada
Martina Recalde
Elena Roel
Karishma Shah
Nigam Shah
Lisa M Schilling
Vignesh Subbian
David Vizcaya
Andrew Williams
Lin Zhang
Ying Zhang
Hong Zhu
Li Liu
Peter Rijnbeek
George Hripcsak
Jennifer C.E Lane
Edward Burn
Christian Reich
Marc A Suchard
Talita Duarte-Salles
Kristin Kostka
Patrick B Ryan
Daniel Prieto-Alhambra

September 2020

Objectives: A plethora of medicines have been repurposed or used as adjunctive therapies for COVID-1...

Use of repurposed and adjuvant drugs in hospital patients with covid-19: Multinational network cohort study

Prats-Uribe, A.
Sena, A.G.
Lai, L.Y.H.
Ahmed, W.-U.-R.
Alghoul, H.
Alser, O.
Alshammari, T.M.
Areia, C.
Carter, W.
Casajust, P.
Dawoud, D.
Golozar, A.
Jonnagaddala, J.
Mehta, P.P.
Gong, M.
Morales, D.R.
Nyberg, F.
Posada, J.D.
Recalde, M.
Roel, E.
Shah, K.
Shah, N.H.
Schilling, L.M.
Subbian, V.
Vizcaya, D.
Zhang, L.
Zhang, Y.
Zhu, H.
Liu, L.
Cho, J.
Lynch, K.E.
Matheny, M.E.
You, S.C.
Rijnbeek, P.R.
Hripcsak, G.
Lane, J.C.E.
Burn, E.
Reich, C.
Suchard, M.A.
Duarte-Salles, T.
Kostka, K.
Ryan, P.B.
Prieto-Alhambra, D.

January 2021

Objective To investigate the use of repurposed and adjuvant drugs in patients admitted to hospital w...

Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort study

Albert Prats-Uribe
Anthony G Sena
Lana Yin Hui Lai
Waheed-Ul-Rahman Ahmed
Heba Alghoul
Osaid Alser
Thamir M Alshammari
Carlos Areia
William Carter
Paula Casajust
Dalia Dawoud
Asieh Golozar
Jitendra Jonnagaddala
Paras P Mehta
Mengchun Gong
Daniel R Morales
Fredrik Nyberg
Jose D Posada
Martina Recalde
Elena Roel
Karishma Shah
Nigam H Shah
Lisa M Schilling
Vignesh Subbian
David Vizcaya
Lin Zhang
Ying Zhang
Hong Zhu
Li Liu
Jaehyeong Cho
Kristine E Lynch
Michael E Matheny
Seng Chan You
Peter R Rijnbeek
George Hripcsak
Jennifer CE Lane
Edward Burn
Christian Reich
Marc A Suchard
Talita Duarte-Salles
Kristin Kostka
Patrick B Ryan
Daniel Prieto-Alhambra

April 2021

Objective - To investigate the use of repurposed and adjuvant drugs in patients admitted to hospital...

Repeated cross-sectional analysis of hydroxychloroquine deimplementation in the AHA COVID-19 CVD Registry.

Bradley, Steven M
Emmons-Bell, Sophia
Mutharasan, R Kannan
Rodriguez, Fatima
Gupta, Divya
Roth, Gregory
Gluckman, Ty J
Shah, Rashmee U
Wang, Tracy Y
Khera, Rohan
Peterson, Pamela N
Das, Sandeep

July 2021

There is little data describing trends in the use of hydroxychloroquine for COVID-19 following publi...

Use of repurposed and adjuvant drugs in hospital patients with covid-19 : multinational network cohort study

Prats-Uribe, Albert
Sena, Anthony G.
Lai, Lana Yin Hui
Ahmed, Waheed-Ul-Rahman
Alghoul, Heba
Alser, Osaid
Alshammari, Thamir M.
Areia, Carlos
Carter, William
Casajust, Paula
Dawoud, Dalia
Golozar, Asieh
Jonnagaddala, Jitendra
Mehta, Paras P.
Gong, Mengchun
Morales, Daniel R.
Nyberg, Fredrik
Posada, Jose D.
Recalde, Martina
Roel, Elena
Shah, Karishma
Shah, Nigam H.
Schilling, Lisa M.
Subbian, Vignesh
Vizcaya, David
Zhang, Lin
Zhang, Ying
Zhu, Hong
Liu, Li
Cho, Jaehyeong
Lynch, Kristine E.
Matheny, Michael E.
You, Seng Chan
Rijnbeek, Peter R.
Hripcsak, George
Lane, Jennifer C. E.
Burn, Edward
Reich, Christian
Suchard, Marc A.
Duarte-Salles, Talita
Kostka, Kristin
Ryan, Patrick B.
Prieto-Alhambra, Daniel

January 2021

To investigate the use of repurposed and adjuvant drugs in patients admitted to hospital with covid-...

Repeated cross-sectional analysis of hydroxychloroquine deimplementation in the AHA COVID-19 CVD Registry

Steven M. Bradley
Sophia Emmons-Bell
R. Kannan Mutharasan
Fatima Rodriguez
Divya Gupta
Gregory Roth
Ty J. Gluckman
Rashmee U. Shah
Tracy Y. Wang
Rohan Khera
Pamela N. Peterson
Sandeep Das

July 2021

Abstract There is little data describing trends in the use of hydroxychloroquine for COVID-19 follow...

Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort study.

Prats-Uribe, Albert
Sena, Anthony G
Lai, Lana Yin Hui
Ahmed, Waheed-Ul-Rahman
Alghoul, Heba
Alser, Osaid
Alshammari, Thamir M
Areia, Carlos
Carter, William
Casajust, Paula
Dawoud, Dalia
Golozar, Asieh
Jonnagaddala, Jitendra
Mehta, Paras P
Gong, Mengchun
Morales, Daniel R
Nyberg, Fredrik
Posada, Jose D
Recalde, Martina
Roel, Elena
Shah, Karishma
Shah, Nigam H
Schilling, Lisa M
Subbian, Vignesh
Vizcaya, David
Zhang, Lin
Zhang, Ying
Zhu, Hong
Liu, Li
Cho, Jaehyeong
Lynch, Kristine E
Matheny, Michael E
You, Seng Chan
Rijnbeek, Peter R
Hripcsak, George
Lane, Jennifer Ce
Burn, Edward
Reich, Christian
Suchard, Marc A
Duarte-Salles, Talita
Kostka, Kristin
Ryan, Patrick B
Prieto-Alhambra, Daniel

May 2021

ObjectiveTo investigate the use of repurposed and adjuvant drugs in patients admitted to hospital wi...

Prats-Uribe, A
Sena, A
Hui Lai, LY
Ahmed, W-U-R
Alghoul, H
Alser, O
Alshammari, T
Areia, C
Carter, W
Casajust, P
Dawoud, D
Golozar, A
Jonnagaddala, J
Mehta, P
Gong, M
Morales, D
Nyberg, F
Posada, J
Recalde, M
Roel, E
Shah, K
H. Shah, N
Schilling, L
Subbian, V
Vizcaya, D
Williams, A
Zhang, L
Zhang, Y
Zhu, H
Liu, L
Rijnbeek, P
Hripcsak, G
Lane, JCE
Burn, E
Reich, C
Suchard, M
Duarte-Salles, T
Kostka, K
Ryan, P
Prieto-Alhambra, D

September 2020

Objectives A plethora of medicines have been repurposed or used as adjunctive therapies for COVID-...

Use of repurposed and adjuvant drugs in hospital patients with covid-19:multinational network cohort study

Prats-Uribe, Albert
Sena, Anthony G.
Lai, Lana Yin Hui
Ahmed, Waheed-Ul-Rahman
Alghoul, Heba
Alser, Osaid
Alshammari, Thamir M.
Areia, Carlos
Carter, William
Casajust, Paula
Dawoud, Dalia
Golozar, Asieh
Jonnagaddala, Jitendra
Mehta, Paras P.
Gong, Mengchun
Morales, Daniel R.
Nyberg, Fredrik
Posada, Jose D.
Recalde, Martina
Roel, Elena
Shah, Karishma
Shah, Nigam H.
Schilling, Lisa M.
Subbian, Vignesh
Vizcaya, David
Zhang, Lin
Zhang, Ying
Zhu, Hong
Liu, Li
Cho, Jaehyeong
Lynch, Kristine E.
Matheny, Michael E.
You, Seng Chan
Rijnbeek, Peter R.
Hripcsak, George
Lane, Jennifer Ce
Burn, Edward
Reich, Christian
Suchard, Marc A.
Duarte-Salles, Talita
Kostka, Kristin
Ryan, Patrick B.
Prieto-Alhambra, Daniel

May 2021

Objective: To investigate the use of repurposed and adjuvant drugs in patients admitted to hospital ...

COVID-19 Evidence Accelerator: A parallel analysis to describe the use of Hydroxychloroquine with or without Azithromycin among hospitalized COVID-19 patients.

Mark Stewart
Carla Rodriguez-Watson
Adem Albayrak
Julius Asubonteng
Andrew Belli
Thomas Brown
Kelly Cho
Ritankar Das
Elizabeth Eldridge
Nicolle Gatto
Alice Gelman
Hanna Gerlovin
Stuart L Goldberg
Eric Hansen
Jonathan Hirsch
Yuk-Lam Ho
Andrew Ip
Monika Izano
Jason Jones
Amy C Justice
Reyna Klesh
Seth Kuranz
Carson Lam
Qingqing Mao
Samson Mataraso
Robertino Mera
Daniel C Posner
Jeremy A Rassen
Anna Siefkas
Andrew Schrag
Georgia Tourassi
Andrew Weckstein
Frank Wolf
Amar Bhat
Susan Winckler
Ellen V Sigal
Jeff Allen

January 2021

BackgroundThe COVID-19 pandemic remains a significant global threat. However, despite urgent need, t...

Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19

Arshad, Samia
Kilgore, Paul
Chaudhry, Zohra S
Jacobsen, Gordon
Wang, Dee Dee
Huitsing, Kylie
Brar, Indira
Alangaden, George
Ramesh, Mayur S
McKinnon, John E
O\u27Neill, William
Zervos, Marcus J

August 2020

SIGNIFICANCE: The United States is in an acceleration phase of the COVID-19 pandemic. Currently ther...

Real-life experience with remdesivir for treatment of hospitalized coronavirus disease 2019 patients: matched case-control study from a large tertiary hospital registry

Lucijanić, Marko
Bušić, Nikolina
Bistrović, Petra
Papić, Ivan
Zelenika Margeta, Marina
Babić, Paško
Barčan, Mihaela
Pasarić, Antica
Mustapić, Mirna
Piskač Živković, Nevenka
Ortner Hadžiabdić, Maja
Lucijanić, Tomo
Lukšić, Ivica
Baršić, Bruno

December 2022

Aim: To evaluate the association of remdesivir use and the survival of hospitalized patients with co...

Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19

Arshad, Samia
Kilgore, Paul
Chaudhry, Zohra S
Jacobsen, Gordon
Wang, Dee Dee
Huitsing, Kylie
Brar, Indira
Alangaden, George J.
Ramesh, Mayur
McKinnon, John
O’Neill, William
Zervos, Marcus
Henry Ford COVID-19 Task Force

January 2020

SIGNIFICANCE: The United States is in an acceleration phase of the COVID-19 pandemic. Currently ther...

Incidence of COVID-19 in patients exposed to chloroquine and hydroxychloroquine : results from a population-based prospective cohort in Catalonia, Spain, 2020

Vivanco-Hidalgo, Rosa Maria
Molina, Israel
Martinez, Elisenda
Roman-Viñas, Ramón
Sánchez-Montalvá, Adrián
Fibla, Joan
Pontes, Caridad
Velasco Muñoz, César

Several clinical trials have assessed the protective potential of chloroquine and hydroxychloroquine...

Pharmacoepidemiology, Machine Learning, and COVID-19: An Intent-to-Treat Analysis of Hydroxychloroquine, With or Without Azithromycin, and COVID-19 Outcomes Among Hospitalized US Veterans.

Gerlovin, Hanna
Posner, Daniel C
Ho, Yuk-Lam
Rentsch, Christopher T
Tate, Janet P
King, Joseph T
Kurgansky, Katherine E
Danciu, Ioana
Costa, Lauren
Linares, Franciel A
Goethert, Ian D
Jacobson, Daniel A
Freiberg, Matthew S
Begoli, Edmon
Muralidhar, Sumitra
Ramoni, Rachel B
Tourassi, Georgia
Gaziano, J Michael
Justice, Amy C
Gagnon, David R
Cho, Kelly

June 2021

Hydroxychloroquine (HCQ) was proposed as an early therapy for coronavirus disease 2019 (COVID-19) af...

Albert Prats-Uribe
Anthony G. Sena
Lana Yin Hui Lai
Waheed-Ul-Rahman Ahmed
Heba Alghoul
Osaid Alser
Thamir M Alshammari
Carlos Areia
William Carter
Paula Casajust
Dalia Dawoud
Asieh Golozar
Jitendra Jonnagaddala
Paras Mehta
Gong Menchung
Daniel R Morales
Fredrik Nyberg
Jose D Posada
Martina Recalde
Elena Roel
Karishma Shah
Nigam Shah
Lisa M Schilling
Vignesh Subbian
David Vizcaya
Andrew Williams
Lin Zhang
Ying Zhang
Hong Zhu
Li Liu
Peter Rijnbeek
George Hripcsak
Jennifer C.E Lane
Edward Burn
Christian Reich
Marc A Suchard
Talita Duarte-Salles
Kristin Kostka
Patrick B Ryan
Daniel Prieto-Alhambra

September 2020

Objectives: A plethora of medicines have been repurposed or used as adjunctive therapies for COVID-1...

Use of repurposed and adjuvant drugs in hospital patients with covid-19: Multinational network cohort study

Prats-Uribe, A.
Sena, A.G.
Lai, L.Y.H.
Ahmed, W.-U.-R.
Alghoul, H.
Alser, O.
Alshammari, T.M.
Areia, C.
Carter, W.
Casajust, P.
Dawoud, D.
Golozar, A.
Jonnagaddala, J.
Mehta, P.P.
Gong, M.
Morales, D.R.
Nyberg, F.
Posada, J.D.
Recalde, M.
Roel, E.
Shah, K.
Shah, N.H.
Schilling, L.M.
Subbian, V.
Vizcaya, D.
Zhang, L.
Zhang, Y.
Zhu, H.
Liu, L.
Cho, J.
Lynch, K.E.
Matheny, M.E.
You, S.C.
Rijnbeek, P.R.
Hripcsak, G.
Lane, J.C.E.
Burn, E.
Reich, C.
Suchard, M.A.
Duarte-Salles, T.
Kostka, K.
Ryan, P.B.
Prieto-Alhambra, D.

January 2021

Objective To investigate the use of repurposed and adjuvant drugs in patients admitted to hospital w...

Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort study

Albert Prats-Uribe
Anthony G Sena
Lana Yin Hui Lai
Waheed-Ul-Rahman Ahmed
Heba Alghoul
Osaid Alser
Thamir M Alshammari
Carlos Areia
William Carter
Paula Casajust
Dalia Dawoud
Asieh Golozar
Jitendra Jonnagaddala
Paras P Mehta
Mengchun Gong
Daniel R Morales
Fredrik Nyberg
Jose D Posada
Martina Recalde
Elena Roel
Karishma Shah
Nigam H Shah
Lisa M Schilling
Vignesh Subbian
David Vizcaya
Lin Zhang
Ying Zhang
Hong Zhu
Li Liu
Jaehyeong Cho
Kristine E Lynch
Michael E Matheny
Seng Chan You
Peter R Rijnbeek
George Hripcsak
Jennifer CE Lane
Edward Burn
Christian Reich
Marc A Suchard
Talita Duarte-Salles
Kristin Kostka
Patrick B Ryan
Daniel Prieto-Alhambra

April 2021

Objective - To investigate the use of repurposed and adjuvant drugs in patients admitted to hospital...

Repeated cross-sectional analysis of hydroxychloroquine deimplementation in the AHA COVID-19 CVD Registry.

Bradley, Steven M
Emmons-Bell, Sophia
Mutharasan, R Kannan
Rodriguez, Fatima
Gupta, Divya
Roth, Gregory
Gluckman, Ty J
Shah, Rashmee U
Wang, Tracy Y
Khera, Rohan
Peterson, Pamela N
Das, Sandeep

July 2021

There is little data describing trends in the use of hydroxychloroquine for COVID-19 following publi...

Use of repurposed and adjuvant drugs in hospital patients with covid-19 : multinational network cohort study

Prats-Uribe, Albert
Sena, Anthony G.
Lai, Lana Yin Hui
Ahmed, Waheed-Ul-Rahman
Alghoul, Heba
Alser, Osaid
Alshammari, Thamir M.
Areia, Carlos
Carter, William
Casajust, Paula
Dawoud, Dalia
Golozar, Asieh
Jonnagaddala, Jitendra
Mehta, Paras P.
Gong, Mengchun
Morales, Daniel R.
Nyberg, Fredrik
Posada, Jose D.
Recalde, Martina
Roel, Elena
Shah, Karishma
Shah, Nigam H.
Schilling, Lisa M.
Subbian, Vignesh
Vizcaya, David
Zhang, Lin
Zhang, Ying
Zhu, Hong
Liu, Li
Cho, Jaehyeong
Lynch, Kristine E.
Matheny, Michael E.
You, Seng Chan
Rijnbeek, Peter R.
Hripcsak, George
Lane, Jennifer C. E.
Burn, Edward
Reich, Christian
Suchard, Marc A.
Duarte-Salles, Talita
Kostka, Kristin
Ryan, Patrick B.
Prieto-Alhambra, Daniel

January 2021

To investigate the use of repurposed and adjuvant drugs in patients admitted to hospital with covid-...

Repeated cross-sectional analysis of hydroxychloroquine deimplementation in the AHA COVID-19 CVD Registry

Steven M. Bradley
Sophia Emmons-Bell
R. Kannan Mutharasan
Fatima Rodriguez
Divya Gupta
Gregory Roth
Ty J. Gluckman
Rashmee U. Shah
Tracy Y. Wang
Rohan Khera
Pamela N. Peterson
Sandeep Das

July 2021

Abstract There is little data describing trends in the use of hydroxychloroquine for COVID-19 follow...

Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort study.

Prats-Uribe, Albert
Sena, Anthony G
Lai, Lana Yin Hui
Ahmed, Waheed-Ul-Rahman
Alghoul, Heba
Alser, Osaid
Alshammari, Thamir M
Areia, Carlos
Carter, William
Casajust, Paula
Dawoud, Dalia
Golozar, Asieh
Jonnagaddala, Jitendra
Mehta, Paras P
Gong, Mengchun
Morales, Daniel R
Nyberg, Fredrik
Posada, Jose D
Recalde, Martina
Roel, Elena
Shah, Karishma
Shah, Nigam H
Schilling, Lisa M
Subbian, Vignesh
Vizcaya, David
Zhang, Lin
Zhang, Ying
Zhu, Hong
Liu, Li
Cho, Jaehyeong
Lynch, Kristine E
Matheny, Michael E
You, Seng Chan
Rijnbeek, Peter R
Hripcsak, George
Lane, Jennifer Ce
Burn, Edward
Reich, Christian
Suchard, Marc A
Duarte-Salles, Talita
Kostka, Kristin
Ryan, Patrick B
Prieto-Alhambra, Daniel

May 2021

ObjectiveTo investigate the use of repurposed and adjuvant drugs in patients admitted to hospital wi...

Prats-Uribe, A
Sena, A
Hui Lai, LY
Ahmed, W-U-R
Alghoul, H
Alser, O
Alshammari, T
Areia, C
Carter, W
Casajust, P
Dawoud, D
Golozar, A
Jonnagaddala, J
Mehta, P
Gong, M
Morales, D
Nyberg, F
Posada, J
Recalde, M
Roel, E
Shah, K
H. Shah, N
Schilling, L
Subbian, V
Vizcaya, D
Williams, A
Zhang, L
Zhang, Y
Zhu, H
Liu, L
Rijnbeek, P
Hripcsak, G
Lane, JCE
Burn, E
Reich, C
Suchard, M
Duarte-Salles, T
Kostka, K
Ryan, P
Prieto-Alhambra, D

September 2020

Objectives A plethora of medicines have been repurposed or used as adjunctive therapies for COVID-...

Use of repurposed and adjuvant drugs in hospital patients with covid-19:multinational network cohort study

Prats-Uribe, Albert
Sena, Anthony G.
Lai, Lana Yin Hui
Ahmed, Waheed-Ul-Rahman
Alghoul, Heba
Alser, Osaid
Alshammari, Thamir M.
Areia, Carlos
Carter, William
Casajust, Paula
Dawoud, Dalia
Golozar, Asieh
Jonnagaddala, Jitendra
Mehta, Paras P.
Gong, Mengchun
Morales, Daniel R.
Nyberg, Fredrik
Posada, Jose D.
Recalde, Martina
Roel, Elena
Shah, Karishma
Shah, Nigam H.
Schilling, Lisa M.
Subbian, Vignesh
Vizcaya, David
Zhang, Lin
Zhang, Ying
Zhu, Hong
Liu, Li
Cho, Jaehyeong
Lynch, Kristine E.
Matheny, Michael E.
You, Seng Chan
Rijnbeek, Peter R.
Hripcsak, George
Lane, Jennifer Ce
Burn, Edward
Reich, Christian
Suchard, Marc A.
Duarte-Salles, Talita
Kostka, Kristin
Ryan, Patrick B.
Prieto-Alhambra, Daniel

May 2021

Objective: To investigate the use of repurposed and adjuvant drugs in patients admitted to hospital ...

COVID-19 Evidence Accelerator: A parallel analysis to describe the use of Hydroxychloroquine with or without Azithromycin among hospitalized COVID-19 patients.

Mark Stewart
Carla Rodriguez-Watson
Adem Albayrak
Julius Asubonteng
Andrew Belli
Thomas Brown
Kelly Cho
Ritankar Das
Elizabeth Eldridge
Nicolle Gatto
Alice Gelman
Hanna Gerlovin
Stuart L Goldberg
Eric Hansen
Jonathan Hirsch
Yuk-Lam Ho
Andrew Ip
Monika Izano
Jason Jones
Amy C Justice
Reyna Klesh
Seth Kuranz
Carson Lam
Qingqing Mao
Samson Mataraso
Robertino Mera
Daniel C Posner
Jeremy A Rassen
Anna Siefkas
Andrew Schrag
Georgia Tourassi
Andrew Weckstein
Frank Wolf
Amar Bhat
Susan Winckler
Ellen V Sigal
Jeff Allen

January 2021

BackgroundThe COVID-19 pandemic remains a significant global threat. However, despite urgent need, t...

Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19

Arshad, Samia
Kilgore, Paul
Chaudhry, Zohra S
Jacobsen, Gordon
Wang, Dee Dee
Huitsing, Kylie
Brar, Indira
Alangaden, George
Ramesh, Mayur S
McKinnon, John E
O\u27Neill, William
Zervos, Marcus J

August 2020

SIGNIFICANCE: The United States is in an acceleration phase of the COVID-19 pandemic. Currently ther...

Real-life experience with remdesivir for treatment of hospitalized coronavirus disease 2019 patients: matched case-control study from a large tertiary hospital registry

Lucijanić, Marko
Bušić, Nikolina
Bistrović, Petra
Papić, Ivan
Zelenika Margeta, Marina
Babić, Paško
Barčan, Mihaela
Pasarić, Antica
Mustapić, Mirna
Piskač Živković, Nevenka
Ortner Hadžiabdić, Maja
Lucijanić, Tomo
Lukšić, Ivica
Baršić, Bruno

December 2022

Aim: To evaluate the association of remdesivir use and the survival of hospitalized patients with co...

Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19

Arshad, Samia
Kilgore, Paul
Chaudhry, Zohra S
Jacobsen, Gordon
Wang, Dee Dee
Huitsing, Kylie
Brar, Indira
Alangaden, George J.
Ramesh, Mayur
McKinnon, John
O’Neill, William
Zervos, Marcus
Henry Ford COVID-19 Task Force

January 2020

SIGNIFICANCE: The United States is in an acceleration phase of the COVID-19 pandemic. Currently ther...

Incidence of COVID-19 in patients exposed to chloroquine and hydroxychloroquine : results from a population-based prospective cohort in Catalonia, Spain, 2020

Vivanco-Hidalgo, Rosa Maria
Molina, Israel
Martinez, Elisenda
Roman-Viñas, Ramón
Sánchez-Montalvá, Adrián
Fibla, Joan
Pontes, Caridad
Velasco Muñoz, César

Several clinical trials have assessed the protective potential of chloroquine and hydroxychloroquine...

Pharmacoepidemiology, Machine Learning, and COVID-19: An Intent-to-Treat Analysis of Hydroxychloroquine, With or Without Azithromycin, and COVID-19 Outcomes Among Hospitalized US Veterans.

Gerlovin, Hanna
Posner, Daniel C
Ho, Yuk-Lam
Rentsch, Christopher T
Tate, Janet P
King, Joseph T
Kurgansky, Katherine E
Danciu, Ioana
Costa, Lauren
Linares, Franciel A
Goethert, Ian D
Jacobson, Daniel A
Freiberg, Matthew S
Begoli, Edmon
Muralidhar, Sumitra
Ramoni, Rachel B
Tourassi, Georgia
Gaziano, J Michael
Justice, Amy C
Gagnon, David R
Cho, Kelly

June 2021

Hydroxychloroquine (HCQ) was proposed as an early therapy for coronavirus disease 2019 (COVID-19) af...

Albert Prats-Uribe
Anthony G. Sena
Lana Yin Hui Lai
Waheed-Ul-Rahman Ahmed
Heba Alghoul
Osaid Alser
Thamir M Alshammari
Carlos Areia
William Carter
Paula Casajust
Dalia Dawoud
Asieh Golozar
Jitendra Jonnagaddala
Paras Mehta
Gong Menchung
Daniel R Morales
Fredrik Nyberg
Jose D Posada
Martina Recalde
Elena Roel
Karishma Shah
Nigam Shah
Lisa M Schilling
Vignesh Subbian
David Vizcaya
Andrew Williams
Lin Zhang
Ying Zhang
Hong Zhu
Li Liu
Peter Rijnbeek
George Hripcsak
Jennifer C.E Lane
Edward Burn
Christian Reich
Marc A Suchard
Talita Duarte-Salles
Kristin Kostka
Patrick B Ryan
Daniel Prieto-Alhambra

September 2020

Objectives: A plethora of medicines have been repurposed or used as adjunctive therapies for COVID-1...

Open Forum Infect Dis

Abstract

Extracted data

Open Forum Infect Dis

Abstract

Extracted data

Related items

Related items